These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 34433890)

  • 21. Magnetic anchoring and guidance-assisted endoscopic irreversible electroporation for gastric mucosal ablation: a preclinical study in canine model.
    Li Q; Gao X; Zhang Y; Han X; Li Z; Zhang Y; Wang Y; Liang L; Chu D; Wu Z; Wang B; Wu R; Lv Y; Ren F
    Surg Endosc; 2021 Oct; 35(10):5665-5674. PubMed ID: 33420599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Self-Expandable Electrode Based on Chemically Polished Nickel-Titanium Alloy Wire for Treating Endoluminal Tumors Using Bipolar Irreversible Electroporation.
    Kim SH; Kang JM; Park Y; Jeong S; Na Y; Jung HD; An J; Kim HS; Lee SS; Park JH
    ACS Appl Mater Interfaces; 2023 Jul; 15(29):34475-34487. PubMed ID: 37452740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Percutaneous irreversible electroporation (IRE) of prostate cancer: Contrast-enhanced ultrasound (CEUS) findings during follow up.
    Beyer LP; Pregler B; Nießen C; Michalik K; Haimerl M; Stroszczynski C; Jung EM; Wiggermann P
    Clin Hemorheol Microcirc; 2016; 64(3):501-506. PubMed ID: 27935553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of different applied voltages of irreversible electroporation on prostate cancer in a mouse model.
    Kim HB; Zeng CH; Kim Y; Jeong S; Kim SH; Kang JM; Park Y; Won DS; Kim JW; Ryu DS; Lim B; Park JH
    Sci Rep; 2022 Dec; 12(1):22336. PubMed ID: 36572706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Focal ablation of apical prostate cancer lesions with irreversible electroporation (IRE).
    Blazevski A; Amin A; Scheltema MJ; Balakrishnan A; Haynes AM; Barreto D; Cusick T; Thompson J; Stricker PD
    World J Urol; 2021 Apr; 39(4):1107-1114. PubMed ID: 32488359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of irreversible electroporation on the stomach wall after ablating hepatic tissues.
    Zhang K; Xu G; Qiu R; Wang L; Li J; Qian F
    Biomed Microdevices; 2018 Nov; 20(4):97. PubMed ID: 30406862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electrical and thermal analyses of catheter-based irreversible electroporation of digestive tract.
    Ren F; Li Q; Gao X; Zhu K; Zhang J; Chen X; Yan X; Chu D; Hu L; Gao Z; Wu Z; Wu R; Lv Y
    Int J Hyperthermia; 2019; 36(1):854-867. PubMed ID: 31452435
    [No Abstract]   [Full Text] [Related]  

  • 28. Low-Voltage Irreversible Electroporation Using a Comb-Shaped Contact Electrode.
    Kurata K; Yoshimatsu S; Takamatsu H
    IEEE Trans Biomed Eng; 2020 Feb; 67(2):420-427. PubMed ID: 31059422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histopathological Outcomes after Irreversible Electroporation for Prostate Cancer: Results of an Ablate and Resect Study.
    van den Bos W; Jurhill RR; de Bruin DM; Savci-Heijink CD; Postema AW; Wagstaff PG; Muller BG; Varkarakis IM; Skolarikos A; Zondervan PJ; Laguna Pes MP; de Reijke TM; de la Rosette JJ
    J Urol; 2016 Aug; 196(2):552-9. PubMed ID: 27004693
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Focal irreversible electroporation as primary treatment for localized prostate cancer.
    van den Bos W; Scheltema MJ; Siriwardana AR; Kalsbeek AMF; Thompson JE; Ting F; Böhm M; Haynes AM; Shnier R; Delprado W; Stricker PD
    BJU Int; 2018 May; 121(5):716-724. PubMed ID: 28796935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Irreversible electroporation. Current value for focal treatment of prostate cancer].
    Wendler JJ; Ganzer R; Hadaschik B; Blana A; Henkel T; Köhrmann KU; Machtens S; Roosen A; Salomon G; Sentker L; Witzsch U; Schlemmer HP; Baumunk D; Köllermann J; Schostak M; Liehr UB;
    Urologe A; 2015 Jun; 54(6):854-62. PubMed ID: 26024649
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of Focal vs Extended Irreversible Electroporation for the Ablation of Localized Low- or Intermediate-Risk Prostate Cancer on Early Oncological Control: A Randomized Clinical Trial.
    Zhang K; Teoh J; Laguna P; Dominguez-Escrig J; Barret E; Ramon-Borja JC; Muir G; Bohr J; de Reijke TM; Pelechano Gómez P; Ng CF; Sanchez-Salas R; de la Rosette J
    JAMA Surg; 2023 Apr; 158(4):343-349. PubMed ID: 36723911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oncological and Quality-of-life Outcomes Following Focal Irreversible Electroporation as Primary Treatment for Localised Prostate Cancer: A Biopsy-monitored Prospective Cohort.
    Blazevski A; Scheltema MJ; Yuen B; Masand N; Nguyen TV; Delprado W; Shnier R; Haynes AM; Cusick T; Thompson J; Stricker P
    Eur Urol Oncol; 2020 Jun; 3(3):283-290. PubMed ID: 31103721
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Focal therapy for prostate cancer with irreversible electroporation: Oncological and functional results of a single institution study.
    Yaxley WJ; Gianduzzo T; Kua B; Oxford R; Yaxley JW
    Investig Clin Urol; 2022 May; 63(3):285-293. PubMed ID: 35534217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Electrical breakdown in tissue electroporation.
    Guenther E; Klein N; Mikus P; Stehling MK; Rubinsky B
    Biochem Biophys Res Commun; 2015 Nov; 467(4):736-41. PubMed ID: 26482855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Feasibility of Concentric Electrodes in Contact Irreversible Electroporation for Superficial Lesion Treatment.
    Kurata K; Naito H; Takamatsu H
    IEEE Trans Biomed Eng; 2022 Aug; 69(8):2480-2487. PubMed ID: 35226598
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigating the effect of electrode orientation on irreversible electroporation with experiment and simulation.
    Wardhana G; Raman NM; Abayazid M; Fütterer JJ
    Int J Comput Assist Radiol Surg; 2022 Aug; 17(8):1399-1407. PubMed ID: 35451675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Irreversible Electroporation in the Epidural Space of the Porcine Spine: Effects on Adjacent Structures.
    Tam AL; Figueira TA; Gagea M; Ensor JE; Dixon K; McWatters A; Gupta S; Fuentes DT
    Radiology; 2016 Dec; 281(3):763-771. PubMed ID: 27266723
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of Irreversible Electroporation Ablation with a Validated Perfused Organ Model.
    Bhonsle S; Bonakdar M; Neal RE; Aardema C; Robertson JL; Howarth J; Kavnoudias H; Thomson KR; Goldberg SN; Davalos RV
    J Vasc Interv Radiol; 2016 Dec; 27(12):1913-1922.e2. PubMed ID: 27663353
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Introduction to Irreversible Electroporation--Principles and Techniques.
    Thomson KR; Kavnoudias H; Neal RE
    Tech Vasc Interv Radiol; 2015 Sep; 18(3):128-34. PubMed ID: 26365541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.